|Bid||239.98 x 800|
|Ask||255.00 x 900|
|Day's range||240.68 - 245.79|
|52-week range||140.53 - 258.00|
|Beta (5Y monthly)||0.79|
|PE ratio (TTM)||63.23|
|Earnings date||27 Oct 2020|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||23 Nov 2012|
|1y target est||259.50|
Masimo (MASI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Masimo (NASDAQ: MASI) will release third quarter 2020 financial results for the period ended September 26, 2020, after the market closes on Tuesday, October 27, 2020. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice President and Chief Financial Officer.
Dr. Augusto Sola, VP of Medical Affairs for Neonatology at Masimo, has been honored by the AAP for his contributions to newborn health.